Advance Care Planning in Palliative Care

Palliative Care Clinical Trial

— ANTICIPALL  

Official title:

What Are the Views of Palliative Care Patients Regarding the Use of Anticipatory Prescribing ?

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05662917
• Other study ID #: 69HCL22_0747
• Secondary ID: ID-RCB
• Status: Recruiting
• Start date: March 10, 2023
• Est. completion date: December 10, 2023

Study information

• Verified date: August 2023
• Source: Hospices Civils de Lyon
• Contact: Manon JULLIAN
• Phone: 4 78 07 30 91
• Email: manonjullian[@]hotmail.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The question of the end of life is a major public health issue. In the field of palliative care, the notion of anticipation is central for people with a serious and progressive illness. Indeed, an important consideration for general practitioners is the need to anticipate the disease's evolution and the uncomfortable symptoms (physical or psychological) the patient is likely to experience. This approach aims to relieve the patient without delay and thus improve comfort to ensure an acceptable quality of life for patients and their families. Even if the usefulness of anticipatory prescribing seems obvious, their use is not generalized to all palliative care patients. Caregivers are confronted with obstacles to the implementation of these prescriptions, particularly with regard to the relationship with the patient. It can then be assumed that patients' experiences and perceptions may influence symptom management and the use of anticipatory prescriptions. It seems essential to explore this subject. For this purpose, the investigator will carry out a qualitative study based on individual semi-structured interviews with palliative care patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10
• Est. completion date: December 10, 2023
• Est. primary completion date: December 10, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Persons of all genders

• Persons 18 years of age and older

• In a palliative care situation of any serious illness

• Persons hospitalized in palliative care unit at the Givors hospital or followed at home by the Mobile Palliative Care Team

• Patients who have received full information about the study and signed a written consent.

Exclusion Criteria:

• Persons under legal protection

• Persons unable to express their consent, making it impossible to conduct interviews:

dysarthria, cognitive disorders, mental confusion, altered state of consciousness

• Pregnant or breastfeeding persons

Related Conditions & MeSH terms

• Palliative Care

Intervention

Behavioral:
• Individual semi-structured interviews
After information and written consent, the investigator will interview the participants through a semi-structured individual interview (conducted by an interview guide). The interview is expected to last 45 minutes (variable depending on the subject). It will be recorded by dictaphone, respecting the anonymity of the participant throughout the interview. The subject's participation will end after the interview.

Locations

Country	Name	City	State
France	Givors Hospital Center - Multidisciplinary medicine and palliative care department	Givors

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary outcome is patient views on the use of anticipatory prescribing.	The interview consists in exploring the participants' experiences (feelings, representations), expectations and difficulties concerning the use of anticipatory prescribing. Interviews will be audio recorded. The verbatim will be transcribed for qualitative analysis by inductive thematic type, in order to bring out the main ideas and hypotheses.	The outcome will be collected at Day 1-End of study visit